OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced PharmaCielo Ltd. (TSX-V: PCLO;  OTCQX: PCLOF), a company focused on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products, has qualified to trade on the OTCQX® Best Market.

PharmaCielo begins trading today on OTCQX under the symbol “PCLOF.”  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

“PharmaCielo joins more than 60 Canadian listed company to begin cross-trading its shares in the U.S. on the OTCQX Market this year,” said Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group. “We are pleased to support companies that are looking to build visibility and provide transparency for their investors in the U.S. public market. Congratulations to PharmaCielo on qualifying for the OTCQX Market.”

“Having our shares traded on the top-tier of the OTC Markets is a testament to PharmaCielo’s successful transition from the start-up phase into a mature medicinal cannabis company with robust operating infrastructure,” said David Attard, CEO of PharmaCielo Ltd. “Being traded on the OTCQX Market is expected to provide PharmaCielo with greater visibility for U.S. and international investors who are looking for opportunities to participate in the burgeoning global medical cannabis industry.”

McMillan LLP acted as the company’s OTCQX sponsor.

SOURCE OTC Markets Group Inc.